vs

Side-by-side financial comparison of Alpha Cognition Inc. (ACOG) and Align Technology (ALGN). Click either name above to swap in a different company.

Align Technology is the larger business by last-quarter revenue ($1.0B vs $2.8M, roughly 375.1× Alpha Cognition Inc.). Align Technology runs the higher net margin — 13.0% vs -245.5%, a 258.4% gap on every dollar of revenue. Align Technology produced more free cash flow last quarter ($187.3M vs $-7.1M).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

ACOG vs ALGN — Head-to-Head

Bigger by revenue
ALGN
ALGN
375.1× larger
ALGN
$1.0B
$2.8M
ACOG
Higher net margin
ALGN
ALGN
258.4% more per $
ALGN
13.0%
-245.5%
ACOG
More free cash flow
ALGN
ALGN
$194.3M more FCF
ALGN
$187.3M
$-7.1M
ACOG

Income Statement — Q4 2025 vs Q4 2025

Metric
ACOG
ACOG
ALGN
ALGN
Revenue
$2.8M
$1.0B
Net Profit
$-6.9M
$135.8M
Gross Margin
65.3%
Operating Margin
-283.7%
14.8%
Net Margin
-245.5%
13.0%
Revenue YoY
5.3%
Net Profit YoY
30.8%
EPS (diluted)
$-0.10
$1.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACOG
ACOG
ALGN
ALGN
Q4 25
$2.8M
$1.0B
Q3 25
$2.8M
$995.7M
Q2 25
$1.7M
$1.0B
Q1 25
$2.9M
$979.3M
Q4 24
$995.2M
Q3 24
$977.9M
Q2 24
$1.0B
Q1 24
$997.4M
Net Profit
ACOG
ACOG
ALGN
ALGN
Q4 25
$-6.9M
$135.8M
Q3 25
$-1.3M
$56.8M
Q2 25
$-10.5M
$124.6M
Q1 25
$-2.0M
$93.2M
Q4 24
$103.8M
Q3 24
$116.0M
Q2 24
$96.6M
Q1 24
$105.0M
Gross Margin
ACOG
ACOG
ALGN
ALGN
Q4 25
65.3%
Q3 25
64.2%
Q2 25
96.7%
69.9%
Q1 25
99.6%
69.5%
Q4 24
70.0%
Q3 24
69.7%
Q2 24
70.3%
Q1 24
70.0%
Operating Margin
ACOG
ACOG
ALGN
ALGN
Q4 25
-283.7%
14.8%
Q3 25
-187.0%
9.7%
Q2 25
-346.1%
16.1%
Q1 25
-125.9%
13.4%
Q4 24
14.5%
Q3 24
16.6%
Q2 24
14.3%
Q1 24
15.5%
Net Margin
ACOG
ACOG
ALGN
ALGN
Q4 25
-245.5%
13.0%
Q3 25
-46.4%
5.7%
Q2 25
-632.7%
12.3%
Q1 25
-68.5%
9.5%
Q4 24
10.4%
Q3 24
11.9%
Q2 24
9.4%
Q1 24
10.5%
EPS (diluted)
ACOG
ACOG
ALGN
ALGN
Q4 25
$-0.10
$1.88
Q3 25
$-0.30
$0.78
Q2 25
$-0.65
$1.72
Q1 25
$-0.13
$1.27
Q4 24
$1.40
Q3 24
$1.55
Q2 24
$1.28
Q1 24
$1.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACOG
ACOG
ALGN
ALGN
Cash + ST InvestmentsLiquidity on hand
$66.0M
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$62.5M
$4.0B
Total Assets
$79.7M
$6.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACOG
ACOG
ALGN
ALGN
Q4 25
$66.0M
$1.1B
Q3 25
$35.4M
$1.0B
Q2 25
$39.4M
$901.2M
Q1 25
$45.5M
$873.0M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$761.4M
Q1 24
$865.8M
Stockholders' Equity
ACOG
ACOG
ALGN
ALGN
Q4 25
$62.5M
$4.0B
Q3 25
$33.9M
$4.0B
Q2 25
$31.9M
$3.9B
Q1 25
$40.8M
$3.8B
Q4 24
$3.9B
Q3 24
$3.9B
Q2 24
$3.8B
Q1 24
$3.8B
Total Assets
ACOG
ACOG
ALGN
ALGN
Q4 25
$79.7M
$6.2B
Q3 25
$46.3M
$6.2B
Q2 25
$45.1M
$6.2B
Q1 25
$48.6M
$6.1B
Q4 24
$6.2B
Q3 24
$6.4B
Q2 24
$6.2B
Q1 24
$6.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACOG
ACOG
ALGN
ALGN
Operating Cash FlowLast quarter
$-6.9M
$223.2M
Free Cash FlowOCF − Capex
$-7.1M
$187.3M
FCF MarginFCF / Revenue
-252.6%
17.9%
Capex IntensityCapex / Revenue
5.3%
3.4%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$-20.7M
$490.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACOG
ACOG
ALGN
ALGN
Q4 25
$-6.9M
$223.2M
Q3 25
$-5.3M
$188.7M
Q2 25
$-6.1M
$128.7M
Q1 25
$-2.0M
$52.7M
Q4 24
$286.1M
Q3 24
$263.7M
Q2 24
$159.8M
Q1 24
$28.7M
Free Cash Flow
ACOG
ACOG
ALGN
ALGN
Q4 25
$-7.1M
$187.3M
Q3 25
$-5.4M
$169.0M
Q2 25
$-6.1M
$107.2M
Q1 25
$-2.1M
$27.4M
Q4 24
$263.1M
Q3 24
$233.9M
Q2 24
$106.4M
Q1 24
$19.3M
FCF Margin
ACOG
ACOG
ALGN
ALGN
Q4 25
-252.6%
17.9%
Q3 25
-188.8%
17.0%
Q2 25
-370.9%
10.6%
Q1 25
-72.0%
2.8%
Q4 24
26.4%
Q3 24
23.9%
Q2 24
10.3%
Q1 24
1.9%
Capex Intensity
ACOG
ACOG
ALGN
ALGN
Q4 25
5.3%
3.4%
Q3 25
2.6%
2.0%
Q2 25
0.5%
2.1%
Q1 25
2.2%
2.6%
Q4 24
2.3%
Q3 24
3.0%
Q2 24
5.2%
Q1 24
0.9%
Cash Conversion
ACOG
ACOG
ALGN
ALGN
Q4 25
1.64×
Q3 25
3.33×
Q2 25
1.03×
Q1 25
0.57×
Q4 24
2.76×
Q3 24
2.27×
Q2 24
1.66×
Q1 24
0.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons